Preleukemia  >>  cyclosporine  >>  Phase 3
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
cyclosporine / Generic mfg.
A BMT Study, NCT00005866: S9920 Busulfan Compared With Cyclophosphamide in Patients Undergoing Total-Body Irradiation Plus Peripheral Stem Cell Transplantation for Advanced Myelodysplastic Syndrome or Related Acute Myeloid Leukemia

Completed
3
240
US, Canada
busulfan, cyclophosphamide, cyclosporine, methotrexate, allogeneic bone marrow transplantation, radiation therapy
Southwest Oncology Group, National Cancer Institute (NCI)
Leukemia, Myelodysplastic Syndromes
03/04
03/06
SAKK 33/99, NCT00004208: Antithymocyte Globulin and Cyclosporine in Treating Patients With Myelodysplastic Syndrome

Completed
3
86
Europe
ATG + CSA, Supportive care
Swiss Group for Clinical Cancer Research
Myelodysplastic Syndromes
10/06
10/11
NCT00003187: Bone Marrow Transplantation in Treating Patients With Leukemia, Myelodysplasia, or Lymphoblastic Lymphoma

Completed
2/3
19
US
filgrastim, cyclophosphamide, cyclosporine, cytarabine, methotrexate, methylprednisolone, allogeneic bone marrow transplantation, in vitro-treated bone marrow transplantation, radiation therapy
Virginia Commonwealth University, National Cancer Institute (NCI)
Leukemia, Lymphoma, Myelodysplastic Syndromes
02/05
02/05

Download Options